Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340142 · ClinicalTrials.gov registry record · NA
VIVO™ Accuracy Study
A NA study of Ventricular Tachycardia and Premature Ventricular Contraction, sponsored by Catheter Precision..
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 3
- Study locations
NCT03340142: Completed NA study of Ventricular Tachycardia and Premature Ventricular Contraction, sponsored by Catheter Precision..
NCT03340142 is a NA study of Ventricular Tachycardia and Premature Ventricular Contraction that has completed, run by Catheter Precision.. The registered enrollment target is 45 participants, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03340142, a NA study of Ventricular Tachycardia and Premature Ventricular Contraction, has completed, sponsored by Catheter Precision..
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 3
- Study locations
Study Summary
A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.
Primary Outcome
Determine the accuracy of VIVO in identifying a PVC/VT to the left or right ventricle or the septum. The origin, identified by VIVO, will be compared to the Carto system and the successful ablation location.
Conditions Studied
Interventions
- DEVICE VIVO™
Study Locations (3)
Iowa
- University of Iowa - Iowa City
Maryland
- Johns Hopkins Unveristy - Baltimore
South Carolina
- Medical Unversity of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2018-11-01 |
| Phase | NA |
What the finished NCT03340142 record still lists
NCT03340142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which VIVO™ is the first listed.
NCT03340142 reports a single indexed study location in Iowa, Maryland, South Carolina.
Frequently Asked Questions
What is clinical trial NCT03340142 about?
NCT03340142 is a clinical study titled "VIVO™ Accuracy Study". A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.
What is the current status of trial NCT03340142?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2018-01-29. Estimated completion is 2018-11-01.
What conditions does trial NCT03340142 study?
This clinical trial studies the following conditions: Ventricular Tachycardia, Premature Ventricular Contraction.
What interventions are being tested in trial NCT03340142?
The interventions under investigation include: VIVO™ (DEVICE).
Who is sponsoring clinical trial NCT03340142?
This trial is sponsored by Catheter Precision., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03340142 being conducted?
This trial has 3 study locations across Iowa, Maryland, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03340142's enrollment target sits among peer trials
45 22nd of 28 higher than 7 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI